AAM:
  follow_up_months: 120
  full_name: Age at menopause
  gender: female
  scale: quantitative
AD:
  follow_up_months: 120
  full_name: Alzheimer's disease
  gender: both
  scale: binary
AF:
  follow_up_months: 120
  full_name: Atrial fibrillation
  gender: both
  scale: binary
AMD:
  follow_up_months: 144
  full_name: Age-related macular degeneration
  gender: both
  scale: binary
APOEA:
  follow_up_months: 120
  full_name: Apolipoprotein A
  gender: both
  scale: quantitative
APOEB:
  follow_up_months: 120
  full_name: Apolipoprotein B
  gender: both
  scale: quantitative
AST:
  follow_up_months: 120
  full_name: Asthma
  gender: both
  scale: binary
BC:
  follow_up_months: 120
  full_name: Breast cancer
  gender: female
  scale: binary
BD:
  follow_up_months: 120
  full_name: Bipolar disorder
  gender: both
  scale: binary
BMI:
  follow_up_months: 120
  full_name: Body mass index
  gender: both
  scale: quantitative
CAL:
  follow_up_months: 120
  full_name: Calcium
  gender: both
  scale: quantitative
CD:
  follow_up_months: 120
  full_name: Crohn's disease
  gender: both
  scale: binary
CED:
  follow_up_months: 120
  full_name: Coeliac disease
  gender: both
  scale: binary
CRC:
  follow_up_months: 120
  full_name: Bowel cancer
  gender: both
  scale: binary
CVD_UK:
  follow_up_months: 120
  full_name: Cardiovascular disease UK
  gender: both
  scale: binary
DOA:
  follow_up_months: 120
  full_name: Docosahexaenoic acid
  gender: both
  scale: quantitative
EBMDT:
  follow_up_months: 120
  full_name: Estimated bone mineral density T-score
  gender: both
  scale: quantitative
EGCR:
  follow_up_months: 120
  full_name: Estimated glomerular filtration rate (creatinine based)
  gender: both
  scale: quantitative
EGCY:
  follow_up_months: 120
  full_name: Estimated glomerular filtration rate (cystatin based)
  gender: both
  scale: quantitative
EOC:
  follow_up_months: 120
  full_name: Epithelial ovarian cancer
  gender: female
  scale: binary
HBA1C_DF:
  follow_up_months: 120
  full_name: Glycated haemoglobin (diabetes free)
  gender: both
  scale: quantitative
HDL:
  follow_up_months: 120
  full_name: HDL cholesterol
  gender: both
  scale: quantitative
HEIGHT:
  follow_up_months: 120
  full_name: Height
  gender: both
  scale: quantitative
HT:
  follow_up_months: 120
  full_name: Hypertension
  gender: both
  scale: binary
IOP:
  follow_up_months: 120
  full_name: Intraocular pressure
  gender: both
  scale: quantitative
ISS:
  follow_up_months: 120
  full_name: Ischaemic stroke
  gender: both
  scale: binary
LDL_SF:
  follow_up_months: 120
  full_name: LDL cholesterol (statin free)
  gender: both
  scale: quantitative
MEL:
  follow_up_months: 120
  full_name: Melanoma
  gender: both
  scale: binary
MIE:
  follow_up_months: 120
  full_name: Myocardial infarction extended
  gender: both
  scale: binary
MS:
  follow_up_months: 120
  full_name: Multiple sclerosis
  gender: both
  scale: binary
OP:
  follow_up_months: 120
  full_name: Osteoporosis
  gender: both
  scale: binary
OSFA:
  follow_up_months: 120
  full_name: Omega 6 fatty acids
  gender: both
  scale: quantitative
OTFA:
  follow_up_months: 120
  full_name: Omega 3 fatty acids
  gender: both
  scale: quantitative
PC:
  follow_up_months: 120
  full_name: Prostate cancer
  gender: male
  scale: binary
PD:
  follow_up_months: 120
  full_name: Parkinson's disease
  gender: both
  scale: binary
PDCL:
  follow_up_months: 120
  full_name: Phosphatidylcholines
  gender: both
  scale: quantitative
PFA:
  follow_up_months: 120
  full_name: Polyunsaturated fatty acids
  gender: both
  scale: quantitative
PHG:
  follow_up_months: 120
  full_name: Phosphoglycerides
  gender: both
  scale: quantitative
POAG:
  follow_up_months: 120
  full_name: Primary open angle glaucoma
  gender: both
  scale: binary
PSO:
  follow_up_months: 120
  full_name: Psoriasis
  gender: both
  scale: binary
RA:
  follow_up_months: 120
  full_name: Rheumatoid arthritis
  gender: both
  scale: binary
RHR:
  follow_up_months: 120
  full_name: Resting heart rate
  gender: both
  scale: quantitative
RMNC:
  follow_up_months: 120
  full_name: Remnant cholesterol
  gender: both
  scale: quantitative
SCZ:
  follow_up_months: 120
  full_name: Schizophrenia
  gender: both
  scale: binary
SGM:
  follow_up_months: 120
  full_name: Sphingomyelins
  gender: both
  scale: quantitative
SLE:
  follow_up_months: 120
  full_name: Systemic lupus erythematosus
  gender: both
  scale: binary
T1D:
  follow_up_months: 120
  full_name: Type 1 diabetes
  gender: both
  scale: binary
T2D:
  follow_up_months: 120
  full_name: Type 2 diabetes
  gender: both
  scale: binary
TCH:
  follow_up_months: 120
  full_name: Total cholesterol
  gender: both
  scale: quantitative
TFA:
  follow_up_months: 120
  full_name: Total fatty acids
  gender: both
  scale: quantitative
TTG:
  follow_up_months: 120
  full_name: Total triglycerides
  gender: both
  scale: quantitative
UC:
  follow_up_months: 120
  full_name: Ulcerative colitis
  gender: both
  scale: binary
VTE:
  follow_up_months: 120
  full_name: Venous thromboembolic disease
  gender: both
  scale: binary
